Literature DB >> 6104977

Antinuclear antibodies in patients on acebutolol.

R J Booth, J Y Bullock, J D Wilson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6104977      PMCID: PMC1429946          DOI: 10.1111/j.1365-2125.1980.tb05848.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Antinuclear antibodies in patients receiving non-practolol beta-blockers.

Authors:  J D Wilson; J Y Bullock; D C Sutherland; C Main; K P O'Brien
Journal:  Br Med J       Date:  1978-01-07

2.  Immune reactions associated with practolol therapy.

Authors:  M Levy; D David
Journal:  Int J Clin Pharmacol Biopharm       Date:  1978-10

3.  Development of antinuclear antibodies during acebutolol therapy.

Authors:  R J Cody; L H Calabrese; J D Clough; R C Tarazi; E L Bravo
Journal:  Clin Pharmacol Ther       Date:  1979-06       Impact factor: 6.875

  3 in total
  7 in total

Review 1.  Idiosyncratic drug reactions: possible role of reactive metabolites generated by leukocytes.

Authors:  J P Uetrecht
Journal:  Pharm Res       Date:  1989-04       Impact factor: 4.200

2.  Antinuclear antibodies and acebutolol.

Authors:  M A Martin
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

Review 3.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

4.  Enhancing in vivo effect of propranolol on human lymphocyte function is not due to stereospecific beta-adrenergic blockade.

Authors:  H Mangge; B Pietsch; W Lindner; H Warnkross; G Leb; K Schauenstein
Journal:  Agents Actions       Date:  1993-03

5.  Ocular, systemic and antinuclear antibody changes with acebutolol.

Authors:  J Hosie; S Y Ghafoor
Journal:  J R Coll Gen Pract       Date:  1983-12

Review 6.  Acetylator phenotype and lupus erythematosus.

Authors:  J P Uetrecht; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

Review 7.  Antinuclear antibodies and cardiovascular drugs.

Authors:  J D Wilson
Journal:  Drugs       Date:  1980-04       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.